Skip to main content
. 2009 Sep 7;2009:235868. doi: 10.1155/2009/235868

Table 1.

Plasmids and oligonucleotides used.

Plasmids or oligonucleotides Description Source/reference
Plasmida
(1) pBluescript KS II (+) pKS cloning vector Stratagene
pKS:F09E10.31 F09E10.3 in pBluescript This study
pKS:D1054.81 D1054.8 in pBluescript This study
(2) YEp352 URA3-marked multicopy plasmid [3]
(3) YEp:CTA12 CTA1 behind its own promoter [4]
YEp:F09E10.33 F09E10.3 behind the CTA1 promoter This study
YEp:D1054.83 D1054.8 behind the CTA1 promoter This study
YEp:OAR13 OAR1 behind the CTA1 promoter Z.-J. Chen

oligonucleotideb
Ce OAR1-1 5′ XbaI TTATTCTAGATGAGTGCTTTGCTGGGAGG This study
Ce OAR1-1 3′ XhoI TATTCTCGAGCTACATACTAAATCCACCGG This study
Ce OAR1-2 5′ XbaI TTATTCTAGATGACTCGTTTTGCTGAAAAAGTC This study
Ce OAR1-2 3′ XhoI TATTCTCGAGTTAATGTAAAAGTTTTGCAAAG This study

aThe superscripts following the plasmid designations refer to their parental vectors, for example, pKS:F09E10.31 was derived from (1) pBluescript KS II (+).

bOligonucleotides Ce OAR1-1 refer to F09E10.3 and Ce OAR1-2 to D1054.8.